Growth Metrics

Regeneron Pharmaceuticals (REGN) Shareholder's Equity (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.53%
Dec 31, 2025 0.97%
Sep 30, 2025 3.40%
Jun 30, 2025 1.88%
Mar 31, 2025 0.12%
Dec 31, 2024 0.09%
Sep 30, 2024 3.97%
Jun 30, 2024 4.50%
Mar 31, 2024 3.92%
Dec 31, 2023 4.29%
Sep 30, 2023 3.69%
Jun 30, 2023 2.22%
Mar 31, 2023 3.67%
Dec 31, 2022 5.71%
Sep 30, 2022 3.63%
Jun 30, 2022 3.88%
Mar 31, 2022 6.11%
Dec 31, 2021 8.75%
Sep 30, 2021 14.09%
Jun 30, 2021 26.30%
Mar 31, 2021 8.63%
Dec 31, 2020 8.89%
Sep 30, 2020 11.79%
Jun 30, 2020 -25.35%
Mar 31, 2020 9.41%
Dec 31, 2019 5.57%
Sep 30, 2019 7.67%
Jun 30, 2019 3.29%
Mar 31, 2019 7.85%
Dec 31, 2018 11.30%
Sep 30, 2018 9.49%
Jun 30, 2018 9.42%
Mar 31, 2018 6.89%
Dec 31, 2017 1.53%
Sep 30, 2017 9.62%
Jun 30, 2017 13.45%
Mar 31, 2017 9.37%
Dec 31, 2016 -0.93%
Sep 30, 2016 10.17%
Jun 30, 2016 8.27%
Mar 31, 2016 3.02%
Dec 31, 2015 10.86%
Sep 30, 2015 -1.25%
Jun 30, 2015 12.35%
Mar 31, 2015 16.52%
Dec 31, 2014 -0.06%
Sep 30, 2014 7.72%
Jun 30, 2014 7.13%
Mar 31, 2014 12.55%
Dec 31, 2013 16.24%
Sep 30, 2013 13.18%
Jun 30, 2013 6.19%
Mar 31, 2013 11.92%
Dec 31, 2012 55.90%
Sep 30, 2012 35.54%
Jun 30, 2012 2,031.58%
Mar 31, 2012 -106.34%
Dec 31, 2011 13.42%
Sep 30, 2011 -10.41%
Jun 30, 2011 -7.73%
Mar 31, 2011 -1.84%
Dec 31, 2010 51.64%
Sep 30, 2010 -6.24%
Jun 30, 2010 -3.90%
Mar 31, 2010 -2.64%
Dec 31, 2009 -6.08%
Sep 30, 2009 2.91%